Efforts such as The Cancer Genome Atlas (TCGA) have comprehensively cataloged the litany of somatic alterations occurring in glioblastoma and lower grade gliomas, leading to discoveries such as the importance of IDH1 mutations in the development of a low-grade glioma and secondary glioblastoma (1). The gene discussed is IDH1; the disease is glioma.